AMS Capital’s Hologic HOLX Stock Holding History

AMS Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50,000	Closed	-$1.87M	–	37
2018 Q1	$1.87M	Buy	+50,000	New	+$2.02M	1.67%	17

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AMS Capital's HOLX Position: Q2 2018 in Review

AMS Capital sold out of Hologic (HOLX) in Q2 2018, closing a stake of 50,000 shares — an estimated $1.87M sold.

AMS Capital first reported a position in HOLX in Q1 2018 and held it in 1 quarter. The position peaked at $1.87M in Q1 2018. 450 funds tracked by Wall St. Rank hold HOLX as of Q2 2018.

AMS Capital reported no remaining Hologic position as of Q2 2018 after selling out during the quarter.
AMS Capital sold 50,000 Hologic shares in Q2 2018, an estimated $1.87M.
AMS Capital first reported a position in Hologic in Q1 2018 and held it in 1 quarter.
AMS Capital's Hologic position peaked at $1.87M in Q1 2018.
450 funds tracked by Wall St. Rank held Hologic as of Q2 2018.

Based on AMS Capital's 13F filing for Q2 2018, filed 31 Jul 2018.